From Cat 3 to a Cat 2 Laboratory: How virusPHIX helped the Pasteur Institute with their work on Dengue Virus

Containment laboratories are designed to prevent or control the exposure of laboratory workers, other persons and the environment to the biological agent in use. These laboratories have been categorised into four hazard groups, CL1, CL2, CL3 and CL4. CL1 is deemed the lowest risk, with CL4 classed as the highest. Each level containment laboratory has [...]

2020-05-29T16:12:08+01:00May 29th, 2020|

New virusPHIX Brochure

Following last week's announcement regarding the development of our new reagent, virusPHIX™ and call for trial sites to evaluate it's suitability for COVID-19 testing, we are pleased to share our new product brochure. The virusPHIX™ brochure includes information about its key features, list of viruses it has successfully inactivated, preliminary data regarding inactivation of SARS-CoV-2 [...]

2020-05-27T10:57:32+01:00May 27th, 2020|

Rapid Labs and RNAssist announce development and trials of SARS-COV-2 viral transport medium

May 2020 Press Release Rapid Labs Ltd (Essex, UK), RNAssist (Cambridge, UK) and Qnostics (Glasgow, UK) are currently developing and seeking trial sites to validate the virusPHIX™ RNA stabilisation, cell fixative and virus inactivation reagent for SARS-CoV-2 testing on nasopharangeal swab samples and saliva/sputum samples.  Offer; A universal sample collection tube for liquid samples including; [...]

2020-05-20T11:09:18+01:00May 20th, 2020|